Table 5.
Pancreatic cancer risk in female patients with keloids, stratified by comorbidities.
| Variables | N | Pancreatic cancer | Crude RR (95% CI) | P-value | Adjusted RRa (95% CI) | P-value |
|---|---|---|---|---|---|---|
| Non-keloids group | 43,064 | 22 | 1.00 | 1.00 | ||
| Keloids | 10,762 | 12 | 2.18 (1.08–4.41) | 0.0296 | 2.05 (1.01–4.17) | 0.0459 |
| Liver cirrhosis | ||||||
| No | 53,488 | 33 | 1.00 | 1.00 | ||
| Yes | 338 | 1 | 4.80 (0.66–35.06) | 0.1224 | 1.53 (0.2–11.5) | 0.6772 |
| Chronic pancreatitis | ||||||
| No | 53,707 | 31 | 1.00 | 1.00 | ||
| Yes | 119 | 3 | 43.68 (13.35–142.86) | < 0.0001 | 16.71 (4.91–56.87) | < 0.0001 |
| Diabetes mellitus | ||||||
| No | 48,539 | 24 | 1.00 | 1.00 | ||
| Yes | 5287 | 10 | 3.83 (1.83–8.00) | 0.0004 | 1.22 (0.54–2.73) | 0.6362 |
RR relative risk, 95% CI 95%confidence interval.
aModel adjusted for age group, gender, the residential region and related comorbidities using a Cox proportional-hazards regression model.